ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,827.00
0.28%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.3875
-0.01%
Brent Oil
82.125
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. ChromaDex Corporation (CDXC)

  7. ChromaDex Corporation (CDXC) ニュース

CDXC

ChromaDex (CDXC)

ChromaDex Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CDXC
日付受信時刻ニュースソース見出しコード企業名
2024/06/1321 : 32Business WireChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)NASDAQ:CDXCChromaDex Corporation
2024/06/0721 : 34Business WireChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)NASDAQ:CDXCChromaDex Corporation
2024/06/0421 : 32Business WireChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024NASDAQ:CDXCChromaDex Corporation
2024/05/2321 : 34Business WireChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024NASDAQ:CDXCChromaDex Corporation
2024/05/2221 : 32Business WireChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year AwardNASDAQ:CDXCChromaDex Corporation
2024/05/0905 : 04Business WireChromaDex Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:CDXCChromaDex Corporation
2024/05/0905 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
2024/05/0905 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDXCChromaDex Corporation
2024/04/3021 : 32Business WireChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy SupplementNASDAQ:CDXCChromaDex Corporation
2024/04/2521 : 34Business WireChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®NASDAQ:CDXCChromaDex Corporation
2024/04/2421 : 34Business WireChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:CDXCChromaDex Corporation
2024/04/2321 : 32Business WireChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers MarketNASDAQ:CDXCChromaDex Corporation
2024/03/2621 : 32Business WireChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency ProgramNASDAQ:CDXCChromaDex Corporation
2024/03/0706 : 04Business WireChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 ResultsNASDAQ:CDXCChromaDex Corporation
2024/03/0706 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
2024/03/0706 : 01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CDXCChromaDex Corporation
2024/02/2411 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
2024/02/2410 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
2024/02/2122 : 32Business WireChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024NASDAQ:CDXCChromaDex Corporation
2024/02/0522 : 32Business WireChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024NASDAQ:CDXCChromaDex Corporation
2024/01/2706 : 08Business WireChromaDex to Present at the Lytham Partners 2024 Investor Select ConferenceNASDAQ:CDXCChromaDex Corporation
2023/12/2023 : 04Business WireChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®NASDAQ:CDXCChromaDex Corporation
2023/12/1406 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
2023/12/1300 : 30PR Newswire (US)Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+NASDAQ:CDXCChromaDex Corporation
2023/12/0506 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXCChromaDex Corporation
2023/11/3022 : 34Business WireA Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)NASDAQ:CDXCChromaDex Corporation
2023/11/1522 : 32Business WireNewly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) PatientsNASDAQ:CDXCChromaDex Corporation
2023/11/0922 : 32Business WireChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023NASDAQ:CDXCChromaDex Corporation
2023/11/0906 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXCChromaDex Corporation
2023/11/0906 : 02Business WireChromaDex Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:CDXCChromaDex Corporation
 Showing the most relevant articles for your search:NASDAQ:CDXC

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有